SYSTEMS, CATHETERS, AND METHODS FOR TREATING ALONG THE CENTRAL NERVOUS SYSTEM
Systems, catheters, and methods for accessing and treating along the central nervous system are disclosed. An example system may include a system for ameliorating a symptom of bacterial meningitis in a patient. The system may include a catheter assembly having a first lumen with a distal port and a second lumen with a proximal port, said catheter being adapted to be introduced in a CSF space and said ports being spaced axially apart. A pump may be connectable between the first and second lumens to induce a flow of CSF therebetween. A filter component may be connectable between the first and second lumens. The filter component may be configured to remove one or more meningitis causing bacterial pathogen from the CSF, to thereby condition the cerebrospinal fluid.
1 . A system for ameliorating a symptom of bacterial meningitis in a patient, said system comprising:
a catheter assembly having a first lumen with a distal port and a second lumen with a proximal port, said catheter being adapted to be introduced in a cerebrospinal fluid space and said ports being spaced axially apart;
a pump connectable between the first and second lumens to induce a flow of cerebrospinal fluid therebetween; and
a filter component connectable between the first and second lumens, the filter component configured to remove one or more meningitis causing bacterial pathogen from the cerebrospinal fluid, to thereby condition the cerebrospinal fluid.
2 . The system of claim 1 , wherein the filter component is further configured to remove one or more endotoxins from the cerebrospinal fluid.
3 . The system of claim 1 , wherein the filter component is further configured to remove one or more cytokines from the cerebrospinal fluid.
4 . The system of claim 1 , wherein the filter component comprises a tangential flow filtration (TFF) filter.
5 . The system of claim 1 , wherein the filter component is capable of removing material having a mass in the range of 1 to 500 kDa.
6 . The system of claim 1 , wherein the filter component has a pore size in the range of 0.1 to 5 microns.
7 . The system of claim 1 , wherein the filter component is configured to remove one or more gram-negative bacterial pathogen.
8 . The system of claim 1 , wherein the filter component is configured to remove one or more of Pseudomonas bacteria, Acinetobacter bacteria, Klebsiella bacteria, or combinations thereof.
9 . The system of claim 1 , wherein the filter component is configured to remove one or more meningitis causing bacterial pathogen that is multi-drug resistant.
10 . The system of claim 1 , wherein the catheter assembly comprises a single catheter.
11 . The system of claim 1 , wherein the catheter assembly comprises a first catheter and a second catheter.
12 . The system of claim 11 , wherein the first catheter and the second catheter each comprise a single lumen.
13 . A system for removing materials from cerebrospinal fluid, the system comprising:
a first port for providing access to a cerebrospinal space at a first location;
a first catheter coupled to the first port, the first catheter being designed to remove cerebrospinal fluid from the first location;
a filtration system coupled to the first catheter, the filtration system being designed to filter the cerebrospinal fluid removed from the first location;
a second port for providing access to the cerebrospinal space at a second location; and
a second catheter coupled to the second port, the first catheter being designed to returned the filtered cerebrospinal fluid.
14 . The system of claim 13 , wherein the first location is a lumbar region of a patient.
15 . The system of claim 14 , wherein the second location is adjacent to a cranial region of the patient.
16 . A method for treating meningitis, the method comprising:
removing cerebrospinal fluid from a patient with meningitis;
filtering the cerebrospinal fluid with a filtration system, the filtration system including a 5 kDa tangential flow filter, a 100 kDa tangential flow filter, or both; and
returning the filtered cerebrospinal fluid to the patient.
17 . The method of claim 16 , wherein filtering the cerebrospinal fluid with a filtration system removes one or more meningitis causing bacterial pathogens from the cerebrospinal fluid.
18 . The method of claim 17 , wherein the one or more meningitis causing bacterial pathogens include gram-negative bacteria, Pseudomonas bacteria, Acinetobacter bacteria, Klebsiella bacteria, or combinations thereof
19 . The method of claim 16 , wherein filtering the cerebrospinal fluid with a filtration system removes one or more bacterial endotoxins from the cerebrospinal fluid.
20 . The method of claim 16 , wherein filtering the cerebrospinal fluid with a filtration system removes one or more neuroinflammatory agents from the cerebrospinal fluid.